We are building an AI-driven platform to accelerate and improve drug development and patient monitoring, as well as introduce precision care for patients with neurological disorders using oculometric data captured with a standard webcam or smartphone. We want to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care. Our vision is a world where neurological disorders can be prevented, diagnosed, and treated effectively, and people live longer healthier lives.

Presently, neurological evaluation is highly subjective, non-sensitive, and dependent on manual examination of symptoms, posing a significant challenge for timely diagnosis, patient monitoring, drug development, and precision care. Our AI-driven platform automatically extracts micro-oculometric measures, providing objective and sensitive digital markers for neurological disorders, enabling early diagnosis, accurate monitoring, and precision care. Currently, we are focusing on Alzheimer’s, Parkinson’s Disease, ALS, and Multiple Sclerosis.